Farkas Gyula
Szegedi Tudományegyetem, Általános Orvostudományi Kar, Sebészeti Klinika, Szeged.
Magy Seb. 2011 Apr;64(2):63-8. doi: 10.1556/MaSeb.64.2011.2.2.
Chronic pancreatitis (CP) is a benign inflammatory process, which can cause enlargement of the pancreatic head accompanied by severe pain and weight loss, and often leads to a significant reduction in quality of life (QoL). Basically, the disease is characterised by pain and functional disorders which are initially treated with conservative therapy, but in case of complications (uncontrollable pain or obstruction) surgical treatment is required.
This article reviews the relevant literature of CP treatment, in particular randomized controlled trials and meta-analyses were involved with a comparison of different surgical treatment options for the management of CP complications.
Recent studies have demonstrated that surgical procedures are superior to endoscopic therapy as regards long-term results of QoL and pain control. There was no significant difference found in postoperative pain relief and overall mortality when duodenum-preserving pancreatic head resection (DPPHR) of Beger and its modification (duodenum and organ-preserving pancreatic head resection [DOPPHR]) were compared with pancreatoduodenectomy (PD), but hospital stay, weight gain, exocrine and endocrine insufficiency, and QoL were significantly better in the DPPHR and DOPPHR groups.
DPPHR and PD seem to be equally effective in terms of postoperative pain relief and overall mortality. However, recent data suggest that DOPPHR is superior in the treatment of CP with regard to several peri- and postoperative outcome parameters and QoL. Therefore, this should be the preferable treatment option for CP complications.
慢性胰腺炎(CP)是一种良性炎症过程,可导致胰头肿大,伴有严重疼痛和体重减轻,并常常导致生活质量(QoL)显著下降。基本上,该疾病以疼痛和功能障碍为特征,最初采用保守治疗,但出现并发症(无法控制的疼痛或梗阻)时则需要手术治疗。
本文回顾了CP治疗的相关文献,尤其纳入了随机对照试验和荟萃分析,比较了CP并发症不同手术治疗方案。
近期研究表明,就QoL和疼痛控制的长期结果而言,手术治疗优于内镜治疗。将贝格尔保留十二指肠胰头切除术(DPPHR)及其改良术式(保留十二指肠和器官的胰头切除术[DOPPHR])与胰十二指肠切除术(PD)相比较时,术后疼痛缓解和总体死亡率方面未发现显著差异,但DPPHR组和DOPPHR组的住院时间、体重增加、外分泌和内分泌功能不全以及QoL明显更好。
DPPHR和PD在术后疼痛缓解和总体死亡率方面似乎同样有效。然而,近期数据表明,DOPPHR在CP治疗中,在几个围手术期和术后结局参数以及QoL方面更具优势。因此,这应该是CP并发症的首选治疗方案。